Shiwei Wang is founder of Evomics Medical, an artificial intelligence-based healthcare start-up company working to provide an unprecedented holistic approach to precision medicine, and publisher of The Yuan. Shiwei has a PhD from Peking University, and a former Head of Investment at ShangPharma in Greater China; partner at ShangPharma Capital and Raymoon Capital; an investor in Aprinoia, Elixiron, YL Pharma, Appotronics, and co-founder and former CFO at Maxinovel.